BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,030,908 | -15.9% | 26,666 | -17.9% | 0.18% | -26.1% |
| Q3 2023 | $1,226,249 | -19.2% | 32,492 | -2.4% | 0.24% | -5.9% |
| Q2 2023 | $1,516,738 | +10.4% | 33,291 | -1.7% | 0.26% | +4.5% |
| Q1 2023 | $1,374,173 | +78424.2% | 33,880 | -1.3% | 0.24% | -25.8% |
| Q4 2022 | $1,750 | -99.9% | 34,338 | +4.8% | 0.33% | -3.8% |
| Q3 2022 | $1,765,000 | -16.3% | 32,768 | -0.2% | 0.34% | -7.3% |
| Q2 2022 | $2,108,000 | -17.8% | 32,832 | -0.7% | 0.37% | -6.1% |
| Q1 2022 | $2,563,000 | -9.7% | 33,048 | -0.1% | 0.39% | -7.1% |
| Q4 2021 | $2,839,000 | +5.6% | 33,076 | -1.0% | 0.42% | -3.4% |
| Q3 2021 | $2,688,000 | -3.5% | 33,418 | -3.4% | 0.44% | -6.6% |
| Q2 2021 | $2,786,000 | -4.7% | 34,610 | -0.2% | 0.47% | -10.8% |
| Q1 2021 | $2,923,000 | -0.5% | 34,666 | -5.4% | 0.53% | -7.5% |
| Q4 2020 | $2,939,000 | +0.5% | 36,632 | +0.7% | 0.57% | -12.8% |
| Q3 2020 | $2,924,000 | -6.8% | 36,362 | -0.2% | 0.65% | -12.2% |
| Q2 2020 | $3,138,000 | +6.6% | 36,440 | +0.5% | 0.74% | -8.1% |
| Q1 2020 | $2,943,000 | -2.6% | 36,249 | +0.3% | 0.81% | +15.2% |
| Q4 2019 | $3,021,000 | -5.1% | 36,129 | -0.7% | 0.70% | -9.3% |
| Q3 2019 | $3,183,000 | +6.4% | 36,387 | -0.3% | 0.78% | +3.7% |
| Q2 2019 | $2,991,000 | +0.7% | 36,514 | +0.0% | 0.75% | -1.4% |
| Q1 2019 | $2,969,000 | +18.1% | 36,511 | -4.4% | 0.76% | +7.8% |
| Q4 2018 | $2,514,000 | -14.3% | 38,188 | +0.4% | 0.70% | -5.8% |
| Q3 2018 | $2,932,000 | +5.9% | 38,030 | +1.5% | 0.75% | +0.9% |
| Q2 2018 | $2,768,000 | +14.0% | 37,478 | +0.4% | 0.74% | +15.4% |
| Q1 2018 | $2,428,000 | +3.5% | 37,326 | +2.8% | 0.64% | +9.9% |
| Q4 2017 | $2,346,000 | +0.3% | 36,302 | -2.6% | 0.58% | -1.9% |
| Q3 2017 | $2,338,000 | +4.8% | 37,266 | +1.1% | 0.59% | +2.9% |
| Q2 2017 | $2,231,000 | +12.4% | 36,849 | -3.7% | 0.58% | +6.5% |
| Q1 2017 | $1,984,000 | +15.8% | 38,256 | -1.0% | 0.54% | +12.9% |
| Q4 2016 | $1,714,000 | -8.0% | 38,649 | -1.3% | 0.48% | -9.9% |
| Q3 2016 | $1,864,000 | +1.3% | 39,151 | -3.8% | 0.53% | +0.6% |
| Q2 2016 | $1,840,000 | +16.1% | 40,696 | +5.5% | 0.53% | +11.3% |
| Q1 2016 | $1,585,000 | +11.9% | 38,589 | +4.0% | 0.48% | +9.7% |
| Q4 2015 | $1,416,000 | +0.4% | 37,099 | -13.6% | 0.43% | -3.1% |
| Q3 2015 | $1,410,000 | -10.9% | 42,919 | +89.6% | 0.45% | -3.0% |
| Q2 2015 | $1,583,000 | +4.8% | 22,636 | +2.7% | 0.46% | +2.2% |
| Q1 2015 | $1,510,000 | +2.2% | 22,043 | +9.4% | 0.45% | +1.1% |
| Q4 2014 | $1,477,000 | +405.8% | 20,152 | +395.4% | 0.45% | +365.6% |
| Q3 2014 | $292,000 | +19.2% | 4,068 | +20.0% | 0.10% | +33.3% |
| Q2 2014 | $245,000 | +2.5% | 3,390 | +4.1% | 0.07% | 0.0% |
| Q1 2014 | $239,000 | -19.3% | 3,255 | -23.5% | 0.07% | -25.0% |
| Q4 2013 | $296,000 | +6.1% | 4,255 | 0.0% | 0.10% | -4.0% |
| Q3 2013 | $279,000 | -5.4% | 4,255 | 0.0% | 0.10% | -9.1% |
| Q2 2013 | $295,000 | – | 4,255 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |